Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.

Accepted 2024-04-02 00:00:00 ET · period of report 2024-03-29 · accession 0000950170-24-040162 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-04-02	2024-04-01	ASMB	White Nicole S	Chief Manufacturing Off	S - Sale	$13.07	-197	10.9K	-2%	-$2,575
D	2024-04-02	2024-03-29	ASMB	White Nicole S	Chief Manufacturing Off	A - Grant	$0.00	+17.5K	17.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-04-01	S	D	197	$13.07	10,947	D	—	—	(F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. (F3) Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9.
2	Derivative	Stock Option (right to buy)	2024-03-29	A	A	17,500	$0.00	17,500	D	$13.30 · — to 2034-03-29	17,500 Common Stock	(F4) Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028.